These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3664510)

  • 1. Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody.
    Hnatowich DJ; Gionet M; Rusckowski M; Siebecker DA; Roche J; Shealy D; Mattis JA; Wilson J; McGann J; Hunter RE
    Cancer Res; 1987 Nov; 47(22):6111-7. PubMed ID: 3664510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.
    Hnatowich DJ; Griffin TW; Kosciuczyk C; Rusckowski M; Childs RL; Mattis JA; Shealy D; Doherty PW
    J Nucl Med; 1985 Aug; 26(8):849-58. PubMed ID: 3861793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.
    Rosenblum MG; Murray JL; Haynie TP; Glenn HJ; Jahns MF; Benjamin RS; Frincke JM; Carlo DJ; Hersh EM
    Cancer Res; 1985 May; 45(5):2382-6. PubMed ID: 3986780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.
    Hnatowich DJ; Rusckowski M; Brill AB; Siebecker DA; Misra H; Mardirossian G; Bushe H; Rescigno A; Stevens S; Johnson DK
    Cancer Res; 1990 Nov; 50(22):7272-8. PubMed ID: 2224858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments.
    Kalofonos HP; Sivolapenko GB; Courtenay-Luck NS; Snook DE; Hooker GR; Winter R; McKenzie CG; Taylor-Papadimitriou JJ; Lavender PJ; Epenetos AA
    Cancer Res; 1988 Apr; 48(7):1977-84. PubMed ID: 2832056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.
    Thédrez P; Saccavini JC; Nolibé D; Simoen JP; Guerreau D; Gestin JF; Kremer M; Chatal JF
    Cancer Res; 1989 Jun; 49(11):3081-6. PubMed ID: 2720666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
    Khawli LA; Alauddin MM; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2003 Dec; 18(6):931-40. PubMed ID: 14969605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.
    Chatal JF; Saccavini JC; Gestin JF; Thédrez P; Curtet C; Kremer M; Guerreau D; Nolibé D; Fumoleau P; Guillard Y
    Cancer Res; 1989 Jun; 49(11):3087-94. PubMed ID: 2720667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
    Murray JL; Lamki LM; Shanken LJ; Blake ME; Plager CE; Benjamin RS; Schweighardt S; Unger MW; Rosenblum MG
    Cancer Res; 1988 Aug; 48(15):4417-22. PubMed ID: 3390837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tumor mass and antigenic nature on the biodistribution of labeled monoclonal antibodies in mice.
    Watanabe Y; Endo K; Koizumi M; Kawamura Y; Saga T; Sakahara H; Kuroki M; Matsuoka Y; Konishi J
    Cancer Res; 1989 Jun; 49(11):2884-9. PubMed ID: 2470499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
    Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
    J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patients.
    Griffin TW; Bokhari F; Collins J; Stochl M; Bernier M; Gionet M; Siebecker D; Wertheimer M; Giroves ES; Greenfield L
    Cancer Immunol Immunother; 1989; 29(1):43-50. PubMed ID: 2706639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermia enhances localization of 111In-labeled hapten to bifunctional antibody in human colon tumor xenografts.
    Gridley DS; Ewart KL; Cao JD; Stickney DR
    Cancer Res; 1991 Mar; 51(5):1515-20. PubMed ID: 1997192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human biodistribution of 111In-labeled B72.3 monoclonal antibody.
    Harwood SJ; Carroll RG; Webster WB; Zangara LM; Laven DL; Morrissey MA; Sinni BJ
    Cancer Res; 1990 Feb; 50(3 Suppl):932s-936s. PubMed ID: 2297744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
    Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
    Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of conjugation on the biodistribution of 111In-labelled anti-PAP and anti-PSA monoclonal antibodies examined in nude mice with PC-82 human tumor xenografts.
    Perälä-Heape M; Vihko P; Pelkonen I; Laine A; Vihko R
    In Vivo; 1991; 5(2):159-65. PubMed ID: 1722716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
    Peräalä-Heape M; Vihko P; Vihko R
    Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and metabolism of 111In-labeled monoclonal antibody B6.2 by the rat liver.
    Jones PL; Brown BA; Sands H
    Cancer Res; 1990 Feb; 50(3 Suppl):852s-856s. PubMed ID: 2297733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
    Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.